Wednesday , October 18 2017
Home / Letter From The Editor (page 60)

Letter From The Editor

Letter from the Editor, #654

There are some looming issues in reimbursement for healthcare coming in the next year. If things don’t change prescribers will be faced with a 27% decrease in reimbursement rates for Medicare and Medicaid patients, and many of the practitioners I talk to tell me that they will no longer take ...

Read More »

Editor’s Note DCMS #112

Each week we try to bring you useful information on how to improve your patients’ care. Most of us have come to realize that no one method or idea works for every patient so when our staff selects information for you we try to bring you solutions and ideas from ...

Read More »

Letter from the Editor #653

Hope everyone had a great Thanksgiving and that you found everything you wanted during your Black Friday shopping spree. During the recent Liver Meeting 2012 in Boston there was a presentation on the apparent increase in the risk of liver disease and cirrhosis in type 1 patients. With this in ...

Read More »

Editor’s Note DCMS #111

According to dictionary.com, "iatrogenic" is defined as an adverse effect induced in a patient as the result of a physician’s words or actions, especially as a consequence of taking a drug prescribed by the physician. No other drug causes more iatrogenic events than insulin. This week our Clinical Text discusses the ...

Read More »

Letter from the Editor #652

As we try to address the burgeoning problem of diabetes worldwide, studies dealing with food choices or physical activity always catch our attention. We want to take advantage of the results and apply them to patients regardless of whether the study participants even have diabetes. Even if the trial has only ...

Read More »

Letter from the Editor #651

This week week the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee recommended that degludec, Novo’s new long acting insulin, be approved for use in the United States. There was a lot of the usual fuss about CV studies that seems to go along with with every new diabetes drug, but this ...

Read More »

Editor’s Note, DCMS #109: Hypoglycemia

Hypoglycemia is always on every medical professional’s mind when they think about using insulin. It doesn’t really matter if the patient has type 1 or type 2 diabetes, or is well-controlled or out of control. As long as they are on insulin there is the risk of hypoglycemia. This week’ ...

Read More »